To The Moon

KUALA LUMPUR, Malaysia, December 30, 2024 – VCI Global Limited (NASDAQ: $VCI Global Ltd.(VCIG)$) (“VCI Global,” or the “Company”), today announced that its investment holding arm for artificial intelligence (AI) portfolios, VC AI Limited (“VC.AI”) has invested in Marvis Inc., a Delaware corporation (“Marvis”), an innovative AI startup company, pioneering advanced digital clone AI technology. This investment was made through a Simple Agreement for Future Equity (SAFE), which provided VC.AI to receive Marvis’ equity in the next financing round. The current seed funding round is capped at a valuation of US$30 million. This investment reinforces VCI Global’s commitment to expanding its AI portfolio and fostering innovation in emerging technologies. Marvi

KUALA LUMPUR, Malaysia, Sept. 03, 2024 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (Frankfurt: H0T) (“VCI Global,” “VCIG,” or the “Company”) is pleased to announce that it has secured a ma

NIO's stock rallied significantly yesterday after inspiring Q2 delivery numbers, which more than doubled.The company's financial performance suggests that management prioritizes growth at all costs, w

Biora Therapeutics, Inc. reported first quarter results encapsulating a period during which it has initiated its BT-600 Phase I study, added new collaborators to its BioJet program, completed several cohorts of its clinical study and improved its capital structure. Following the end of the quarter, Biora shared interim results from the BT-600 trial, raised additional capital and completed the multiple-ascending dose portion of the BT-600 trial. Other highlights include the issuance of a new patent and participation in Digestive Disease Week on May 19th. Based on the preclinical work that has been completed so far with collaborators, management is optimistic that they will see a partnership emerge this year.Biora reported first quarter 2024 results in a press release and Form 10-Q filing with the SEC on May 15th. A conference call was held to discuss results with investors following the release. For the quarter ending March 31, 2024 revenues of $542,000 were recognized. Net loss for 1Q

Nio stock investors can't afford to disregard international conflicts as they're bound to impact Nio's top and bottom lines.

AGBA Group Holding Limited's ( NASDAQ:AGBA ) price-to-sales (or "P/S") ratio of 0.5x might make it look like a buy...

Chinese automaker $NIO(NIO)$ is scheduled to announce Q2 earnings results on Tuesday, August 29th, before market open.The consensus EPS estimate is -$0.24 and the consensus revenue estimate is $1.27 b

NIO stock is on shaky ground as Nio refuses to stick to its core business of just selling electric vehicles.